Relating to investigations and disciplinary or punitive action by the Texas Medical Board regarding certain treatments or practices regarding COVID-19 and to the required expungement of certain records.

SB 2422 prohibits the Texas Medical Board from investigating or disciplining healthcare professionals for prescribing or advocating ivermectin, hydroxychloroquine, or budesonide for COVID-19 treatment, making statements about mask effectiveness, or failing to require masks (except in areas where mask-wearing was customary before the pandemic). It requires the Medical Board to expunge all records created since January 1, 2020, containing those drug names or the word "mask" in disciplinary contexts, and to vacate any penalties based on such records. The bill would take effect immediately if passed by a two-thirds vote, or on September 1, 2025, if not.